KeyurPravinchandraPatelMD

PubMed

• Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications.
  Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamanna, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Kadia, ...> ;American Journal of Hematology. 2024 Apr 13
• Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Dia...
  Fouad El Dana, Sofia Alexandra Garces Narvaez, Nader K El-Mallawany, Jennifer E Agrusa, ZoAnn E Dreyer, Andrea N Marcogliese, Mohamed Tarek Elghetany, Jyotinder N Puni...> ;Pediatric and Developmental Pathology. 2024 Mar 11
• Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer.
  Gouda, M., Iorgulescu, J., Shen, T., Wu, J., Subbiah, V., Dadu, R., Patel, K., Sherman, S., Cabanillas, M., Hu, M., Castellanos, L., Amini, B., Meric-Bernstam, F.> ;NPJ Precision Oncology. 2024 Mar 4
• Outcome of Patients With Relapsed Acute Promyelocytic Leukemia.
  Ravandi, F., Pierce, S., Sasaki, K., Kadia, T., DiNardo, C., Yilmaz, M., Short, N., Jabbour, E., Patel, K., Loghavi, S., Borthakur, G., Kantarjian, H.> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 3
• Limited Independent Follow-Up with Germline Testing of Variants Detected inandby Tumor-Only Sequencing.
  Nowlen, C., Daniels, M., Uzunparmak, B., Ileana Dumbrava, E., Yuan, Y., Patel, K., Rayes, N., Harkenrider, J., Wathoo, C., Veazie, J., Luna, K., Wang, W., Horombe, C.,...> ;Journal of Immunotherapy and Precision Oncology. 2024 Feb 1
• Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory-Mutated AML.
  Short, N., Daver, N., Dinardo, C., Kadia, T., Nasr, L., Macaron, W., Yilmaz, M., Borthakur, G., Montalban-Bravo, G., Garcia-Manero, G., Issa, G., Chien, K., Jabbour, E...> ;Journal of Clinical Oncology. 2024 Jan 26
• Intragenic.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors.
  Zheng, L., Luthra, R., Alvarez, H., San Lucas, F., Duose, D., Wistuba, I., Fuller, G., Ballester, L., Roy-Chowdhuri, S., Sweeney, K., Rashid, A., Yang, R., Chen, W., L...> ;Cancers. 2023 Dec 19
• 1 citations
  Predictive and prognostic molecular biomarkers in lymphomas.
  J Bryan Iorgulescu, L Jeffrey Medeiros, Keyur P Patel> ;Pathology. 2024 Mar 1
• 14 citations
  Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia.
  Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, Nicholas J Short, Ghayas C Issa, Abhishek Maiti, Hussein A Abbas, Naval G Daver, Naveen Pemmaraju, Sherry Pierce, Kell...> ;Blood. 2023 Nov 9
• Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic rel...
  L Jeffrey Medeiros, Mario L Marques-Piubelli, Valentina F I Sangiorgio, Roberto Ruiz-Cordero, Francisco Vega, Andrew L Feldman, Jennifer R Chapman, Mark W Clemens, Kel...> ;Modern Pathology. 2023 Dec 1
• Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing.
  J Bryan Iorgulescu, Leah K Shaw, Asif Rashid, Priya Rao, Sreedhar Mandayam, Keyur P Patel, Kathleen M Schmeler, Richard K Yang, Pavlos Msaouel> ;Current Oncology. 2023 Oct 5
• Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center ex...
  John Diks, Zhenya Tang, Mehmet Altan, Sarah Anderson, Hui Chen, Asif Rashid, Richard Kenneth Yang, Mark J Routbort, Keyur P Patel, Gokce A Toruner, L Jeffrey Medeiros,...> ;Cancer Cytopathology. 2024 Jan 1
• 7 citations
  Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
  Alex Bataller, Sanam Loghavi, Yoheved Gerstein, Alexandre Bazinet, Koji Sasaki, Kelly S Chien, Danielle Hammond, Guillermo Montalban-Bravo, Gautam Borthakur, Nicholas ...> ;American Journal of Hematology. 2023 Nov 1
• 1 citations
  Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era.
  Fadi G Haddad, Koji Sasaki, Aram Bidikian, Ghayas C Issa, Tapan Kadia, Nitin Jain, Yesid Alvarado, Nicholas J Short, Naveen Pemmaraju, Sanam Loghavi, Keyur P Patel, Ra...> ;American Journal of Hematology. 2023 Oct 1
• 8 citations
  Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity.
  Alexandre Bazinet, Tapan Kadia, Nicholas J Short, Gautam Borthakur, Sa A Wang, Wei Wang, Sanam Loghavi, Jeffrey Jorgensen, Keyur Patel, Courtney DiNardo, Naval Daver, ...> ;Blood Advances. 2023 Jul 11
• 8 citations
  A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents.
  Nicholas J Short, Muharrem Muftuoglu, Faustine Ong, Lewis Nasr, Walid Macaron, Guillermo Montalban-Bravo, Yesid Alvarado, Mahesh Basyal, Naval Daver, Courtney D Dinard...> ;Journal of Hematology & Oncology. 2023 Jul 8
• 11 citations
  Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1.
  Nicholas J Short, Elias Jabbour, Walid Macaron, Farhad Ravandi, Nitin Jain, Rashmi Kanagal-Shamanna, Keyur P Patel, Sanam Loghavi, Fadi G Haddad, Musa Yilmaz, Ghayas C...> ;American Journal of Hematology. 2023 Aug 1
• 2 citations
  DDX41 mutations in patients with non-myeloid hematologic neoplasms.
  Fatima Zahra Jelloul, Mark J Routbort, Courtney D DiNardo, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamanna, Beenu Thakral, Zhuang Zuo, C Cameron Yin, Sanam Loghavi, Chi ...> ;American Journal of Hematology. 2023 Aug 1
• 2 citations
  Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor inClass Rearrangements.
  Jayastu Senapati, Elias Jabbour, Marina Konopleva, Nicholas J Short, Guilin Tang, Naval Daver, Partow Kebriaei, Tapan Kadia, Naveen Pemmaraju, Koichi Takahashi, Courtn...> ;JCO Precision Oncology. 2023 May 1
• 10 citations
  Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML.
  Ghayas C Issa, Aram Bidikian, Sangeetha Venugopal, Marina Konopleva, Courtney D DiNardo, Tapan M Kadia, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Musa Yilmaz,...> ;Blood Advances. 2023 Mar 28
• Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
  Fatima Zahra Jelloul, Andres E Quesada, Richard K Yang, Shaoying Li, Wei Wang, Jie Xu, Guilin Tang, C Cameron Yin, Hong Fang, Siba El Hussein, Joseph Khoury, Roland L ...> ;Modern Pathology. 2023 Jun 1
• 1 citations
  Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
  Siba El Hussein, L Jeffrey Medeiros, Stephen K Gruschkus, Peng Wei, Ellen Schlette, Hong Fang, Fatima Zahra Jelloul, Wei Wang, Warren Fiskus, Rashmi Kanagal-Shamanna, ...> ;Virchows Archiv. 2023 Jun 1
• 1 citations
  Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
  Siba El Hussein, L Jeffrey Medeiros, Kirill A Lyapichev, Hong Fang, Fatima Zahra Jelloul, Warren Fiskus, Jiansong Chen, Peng Wei, Ellen Schlette, Jie Xu, Shaoying Li, ...> ;Pathology. 2023 Jun 1
• Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.
  Kran Suknuntha, Julia T Geyer, Keyur Pravinchandra Patel, Olga K Weinberg, Heesun J Rogers, Jonathan I Lake, Luke Lauridsen, Jay L Patel, Michael J Kluk, Daniel A Arbe...> ;Leukemia Research. 2023 Apr 1
• 2 citations
  Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia.
  Koji Sasaki, Farhad Ravandi, Tapan M Kadia, Gautam Borthakur, Nicholas J Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia-Manero, Sanam Loghavi, Key...> ;Cancer. 2023 Apr 1
• Join now to see all